Literature DB >> 25192986

Genetic characterization and comparison of Clostridium botulinum isolates from botulism cases in Japan between 2006 and 2011.

Tsuyoshi Kenri1, Tsuyoshi Sekizuka2, Akihiko Yamamoto3, Masaaki Iwaki3, Takako Komiya3, Takashi Hatakeyama4, Hiroshi Nakajima5, Motohide Takahashi3, Makoto Kuroda2, Keigo Shibayama3.   

Abstract

Genetic characterization was performed for 10 group I Clostridium botulinum strains isolated from botulism cases in Japan between 2006 and 2011. Of these, 1 was type A, 2 were type B, and 7 were type A(B) {carrying a silent bont/B [bont/(B)] gene} serotype strains, based on botulinum neurotoxin (BoNT) production. The type A strain harbored the subtype A1 BoNT gene (bont/A1), which is associated with the ha gene cluster. The type B strains carried bont/B5 or bont/B6 subtype genes. The type A(B) strains carried bont/A1 identical to that of type A(B) strain NCTC2916. However, bont/(B) genes in these strains showed single-nucleotide polymorphisms (SNPs) among strains. SNPs at 2 nucleotide positions of bont/(B) enabled classification of the type A(B) strains into 3 groups. Pulsed-field gel electrophoresis (PFGE) and multiple-locus variable-number tandem-repeat analysis (MLVA) also provided consistent separation results. In addition, the type A(B) strains were separated into 2 lineages based on their plasmid profiles. One lineage carried a small plasmid (5.9 kb), and another harbored 21-kb plasmids. To obtain more detailed genetic information about the 10 strains, we sequenced their genomes and compared them with 13 group I C. botulinum genomes in a database using whole-genome SNP analysis. This analysis provided high-resolution strain discrimination and enabled us to generate a refined phylogenetic tree that provides effective traceability of botulism cases, as well as bioterrorism materials. In the phylogenetic tree, the subtype B6 strains, Okayama2011 and Osaka05, were distantly separated from the other strains, indicating genomic divergence of subtype B6 strains among group I strains.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25192986      PMCID: PMC4249013          DOI: 10.1128/AEM.02134-14

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  52 in total

1.  RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models.

Authors:  Alexandros Stamatakis
Journal:  Bioinformatics       Date:  2006-08-23       Impact factor: 6.937

2.  Mapping short DNA sequencing reads and calling variants using mapping quality scores.

Authors:  Heng Li; Jue Ruan; Richard Durbin
Journal:  Genome Res       Date:  2008-08-19       Impact factor: 9.043

3.  Genetic characterization of Clostridium botulinum associated with type B infant botulism in Japan.

Authors:  Kaoru Umeda; Yoshiyuki Seto; Tomoko Kohda; Masafumi Mukamoto; Shunji Kozaki
Journal:  J Clin Microbiol       Date:  2009-07-01       Impact factor: 5.948

4.  The complete genome sequence of Clostridium botulinum F str. 230613, insertion sites, and recombination of BoNT gene clusters.

Authors:  Ren-Mao Tian; Tao Li; Xiao-Jun Hou; Qin Wang; Kun Cai; Yue-Nan Liu; Xiang Gao; Hao Liu; Le Xiao; Wei Tu; Jing Shi; Wu-Chun Cao; Hui Wang
Journal:  Genome       Date:  2011-06-22       Impact factor: 2.166

5.  Genetic interrelationships of saccharolytic Clostridium botulinum types B, E and F and related clostridia as revealed by small-subunit rRNA gene sequences.

Authors:  R A Hutson; D E Thompson; M D Collins
Journal:  FEMS Microbiol Lett       Date:  1993-03-15       Impact factor: 2.742

6.  Presence of soil-dwelling clostridia in commercial powdered infant formulas.

Authors:  Jason R Barash; Jennifer K Hsia; Stephen S Arnon
Journal:  J Pediatr       Date:  2009-12-09       Impact factor: 4.406

Review 7.  Iatrogenic botulism after the therapeutic use of botulinum toxin-A: a case report and review of the literature.

Authors:  Majid Ghasemi; Rasul Norouzi; Mehri Salari; Bahador Asadi
Journal:  Clin Neuropharmacol       Date:  2012 Sep-Oct       Impact factor: 1.592

8.  A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins.

Authors:  Jason R Barash; Stephen S Arnon
Journal:  J Infect Dis       Date:  2013-10-07       Impact factor: 5.226

9.  Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, in neuronal cell cultures, and in vitro.

Authors:  Regina C M Whitemarsh; William H Tepp; Marite Bradshaw; Guangyun Lin; Christina L Pier; Jacob M Scherf; Eric A Johnson; Sabine Pellett
Journal:  Infect Immun       Date:  2013-08-05       Impact factor: 3.441

View more
  13 in total

1.  Implications of Genome-Based Discrimination between Clostridium botulinum Group I and Clostridium sporogenes Strains for Bacterial Taxonomy.

Authors:  Michael R Weigand; Angela Pena-Gonzalez; Timothy B Shirey; Robin G Broeker; Maliha K Ishaq; Konstantinos T Konstantinidis; Brian H Raphael
Journal:  Appl Environ Microbiol       Date:  2015-06-05       Impact factor: 4.792

2.  Pulsotype Diversity of Clostridium botulinum Strains Containing Serotypes A and/or B Genes.

Authors:  Jessica L Halpin; Lavin Joseph; Janet K Dykes; Loretta McCroskey; Elise Smith; Denise Toney; Steven Stroika; Kelley Hise; Susan Maslanka; Carolina Lúquez
Journal:  Foodborne Pathog Dis       Date:  2017-07-10       Impact factor: 3.171

3.  Genomic Characterization of Newly Completed Genomes of Botulinum Neurotoxin-Producing Species from Argentina, Australia, and Africa.

Authors:  Theresa J Smith; Gary Xie; Charles H D Williamson; Karen K Hill; Rafael A Fernández; Jason W Sahl; Paul Keim; Shannon L Johnson
Journal:  Genome Biol Evol       Date:  2020-03-01       Impact factor: 3.416

4.  Genomic Epidemiology of Clostridium botulinum Isolates from Temporally Related Cases of Infant Botulism in New South Wales, Australia.

Authors:  Nadine McCallum; Timothy J Gray; Qinning Wang; Jimmy Ng; Leanne Hicks; Trang Nguyen; Marion Yuen; Grant A Hill-Cawthorne; Vitali Sintchenko
Journal:  J Clin Microbiol       Date:  2015-06-24       Impact factor: 5.948

Review 5.  Impact of Clostridium botulinum genomic diversity on food safety.

Authors:  Michael W Peck; Arnoud Hm van Vliet
Journal:  Curr Opin Food Sci       Date:  2016-08       Impact factor: 6.031

6.  Differentiating Botulinum Neurotoxin-Producing Clostridia with a Simple, Multiplex PCR Assay.

Authors:  Charles H D Williamson; Adam J Vazquez; Karen Hill; Theresa J Smith; Roxanne Nottingham; Nathan E Stone; Colin J Sobek; Jill H Cocking; Rafael A Fernández; Patricia A Caballero; Owen P Leiser; Paul Keim; Jason W Sahl
Journal:  Appl Environ Microbiol       Date:  2017-08-31       Impact factor: 4.792

7.  Genetic Characterization of the Exceptionally High Heat Resistance of the Non-toxic Surrogate Clostridium sporogenes PA 3679.

Authors:  Robert R Butler; Kristin M Schill; Yun Wang; Jean-François Pombert
Journal:  Front Microbiol       Date:  2017-04-03       Impact factor: 5.640

8.  Diversity of Group I and II Clostridium botulinum Strains from France Including Recently Identified Subtypes.

Authors:  Christelle Mazuet; Christine Legeay; Jean Sautereau; Laurence Ma; Christiane Bouchier; Philippe Bouvet; Michel R Popoff
Journal:  Genome Biol Evol       Date:  2016-06-13       Impact factor: 3.416

9.  Comparative genomic analyses reveal broad diversity in botulinum-toxin-producing Clostridia.

Authors:  Charles H D Williamson; Jason W Sahl; Theresa J Smith; Gary Xie; Brian T Foley; Leonard A Smith; Rafael A Fernández; Miia Lindström; Hannu Korkeala; Paul Keim; Jeffrey Foster; Karen Hill
Journal:  BMC Genomics       Date:  2016-03-03       Impact factor: 3.969

Review 10.  Variations in the Botulinum Neurotoxin Binding Domain and the Potential for Novel Therapeutics.

Authors:  Jonathan R Davies; Sai Man Liu; K Ravi Acharya
Journal:  Toxins (Basel)       Date:  2018-10-20       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.